About Farmson Basic Drugs Private Limited
Data last updated:
Farmson Basic Drugs Private Limited is a private limited company based in Nandesari, Gujarat, India, a subsidiary of Farmson Pharmaceutical Gujarat Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24110GJ2020PTC112370. Its GSTIN is 24AAECF0045M2ZS (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹3,893.5 Cr and a paid-up capital of ₹3,891.87 Cr. It is led by directors including Komal Samir Patel and Milin Kaimas Mehta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 14 GIDC Industrial Estate Nandesari, Gujarat, India – 391340.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,222.47 Cr, a decline of 26% compared to the previous year. For the same year it recorded a net loss of ₹215.05 Cr (net margin -17.6%) and EBITDA of ₹46.57 Cr (EBITDA margin 3.8%).
The company has about 966 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹800 Cr on record.
For more details, the company can be reached via its website farmson.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No. 14 GIDC Industrial Estate Nandesari, Gujarat, India – 391340
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Farmson Basic Drugs Private Limited
The main business activity of Farmson Basic Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Farmson Basic Drugs Private Limited FY 2024 filings available
Farmson Basic Drugs Private Limited reported revenue of ₹1,222.47 Cr (down 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Farmson Basic Drugs Private Limited
Revenue fell 26% in the latest year. EBITDA fell 90% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Farmson Basic Drugs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹46.57 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹215.05 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Farmson Basic Drugs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -17.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Farmson Basic Drugs are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Farmson Basic Drugs Private Limited
Farmson Basic Drugs Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Innova Captab Limited | ₹1,255.72 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Thane, Maharashtra, India |
| MPCL Industries Limited | ₹1,254.05 Cr (FY 2024) | •••• | •••• | -14.0% | •••• | Delhi, India |
| Nacl Industries Limited Listed | ₹1,242.56 Cr (FY 2025) | •••• | •••• | -30.0% | •••• | Hyderabad, Telangana, India |
| Cipla Health Limited | ₹1,228.87 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| Neon Laboratories Limited | ₹1,222.81 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Farmson Basic Drugs Private Limited this company | ₹1,222.47 Cr (FY 2025) | •••• | •••• | -26.0% | •••• | Nandesari, Gujarat, India |
| Arysta Lifescience India Limited | ₹1,217.88 Cr (FY 2022) | •••• | •••• | 240.0% | •••• | Mumbai, Maharashtra, India |
| SML Limited | ₹1,214.37 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Cheminova India Limited | ₹1,205.86 Cr (FY 2025) | •••• | •••• | -50.0% | •••• | Mumbai, Maharashtra, India |
| Corona Remedies Limited | ₹1,202.35 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Ahmedabad, Gujarat, India |
| Asian Paints PPG Private Limited | ₹1,199.16 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Farmson Basic Drugs by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Farmson Basic Drugs Private Limited
Farmson Basic Drugs Private Limited is audited by M/s. Shah Mehta And Bakshi for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M/s. Shah Mehta And Bakshi | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Farmson Basic Drugs Private Limited
Farmson Basic Drugs has 8 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Komal Samir Patel | Director | 29 Jan 2020 | 6 Years 8 Months | Current |
| Milin Kaimas Mehta Also directs: Farmson Pharmaceutical Gujarat Private Limited, K C Mehta & Co LLP, Styrenix Performance Materials Limited and 5 more | Director | 15 Mar 2024 | 2 Years 6 Months | Current |
| Apurva Maheshbhai Patel Also directs: Viju Enterprises LLP, Farmson Pharmaceutical Gujarat Private Limited, Viju Enterprises Private Limited and 1 more | Director | 15 Mar 2024 | 2 Years 6 Months | Current |
| Vinit Menon Also directs: K. K. Vithani Foundation | Director | 29 Jan 2020 | 6 Years 8 Months | Current |
| Sudhesh Arjun Prasad Mishra Also directs: K. K. Vithani Foundation | Director | 29 Jan 2020 | 6 Years 8 Months | Current |
| Narshibhai K Patel Also directs: Viju Enterprises LLP, Farmson Pharmaceutical Gujarat Private Limited, Viju Enterprises Private Limited and 1 more | Director | 29 Jan 2020 | 6 Years 8 Months | Current |
Ownership and Shareholding of Farmson Basic Drugs Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Farmson Basic Drugs Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Sep 2025 | Others | ₹250 Cr | Open |
| 09 Apr 2025 | Others | ₹300 Cr | Open |
| 28 Mar 2025 | Others | ₹250 Cr | Open |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Farmson Basic Drugs Private Limited
Farmson Basic Drugs Private Limited has a workforce of 966 employees as of Jun 04, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
News related to Farmson Basic Drugs Private Limited
Recent Activity on Farmson Basic Drugs Private Limited
Farmson Basic Drugs Private Limited has 12 board changes on record since 2020: 9 appointments and 3 cessations. The latest: Aksh Apurva Patel was appointed as Additional Director on 24 Feb 2025.
6 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Farmson Basic Drugs Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Farmson Basic Drugs Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Farmson Basic Drugs Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Farmson Basic Drugs Private Limited
Farmson Basic Drugs has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECF0045M2ZS | Gujarat | Active | 18 Mar 2024 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Farmson Basic Drugs Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Farmson Basic Drugs Private Limited
Farmson Basic Drugs is an active private limited company based in Nandesari, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 January 2020 (6+ years old) and is registered under CIN U24110GJ2020PTC112370.
Farmson Basic Drugs reported revenue of ₹1,222.47 Cr for FY 2025 (down 26% YoY).
Farmson Basic Drugs has 8 current directors:
- Komal Samir Patel - Director
- Milin Kaimas Mehta - Director
- Apurva Maheshbhai Patel - Director
- Vinit Menon - Director
- Sudhesh Arjun Prasad Mishra - Director
- Narshibhai K Patel - Director
- Aksh Apurva Patel - Additional Director
- Archa Ajoy Joshi - Additional Director
Farmson Basic Drugs reported a net loss of ₹215.05 Cr (net margin -17.6%) and EBITDA of ₹46.57 Cr (EBITDA margin 3.8%) for FY 2025, as per its filed financial statements.
The GSTIN of Farmson Basic Drugs is 24AAECF0045M2ZS, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Farmson Basic Drugs is U24110GJ2020PTC112370. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Farmson Basic Drugs was incorporated on 29 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Farmson Basic Drugs by revenue are Innova Captab Limited, MPCL Industries Limited, Nacl Industries Limited, Cipla Health Limited, Neon Laboratories Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Aksh Apurva Patel was appointed as Additional Director on 24 Feb 2025. Archa Ajoy Joshi was appointed as Additional Director on 24 Feb 2025. Apurva Maheshbhai Patel ceased to be Additional Director on 29 Sep 2024. Farmson Basic Drugs has 12 board changes on record in total.
Farmson Basic Drugs can be reached through the website farmson.com. Its registered office is in Nandesari, Gujarat, India.
The registered office of Farmson Basic Drugs is at Plot No. 14 GIDC Industrial Estate Nandesari, Gujarat, India – 391340.